Press Releases

PARIS, June 3, 2024 /PRNewswire/ -- A spectacular, never-before-seen 30-minute experience will open on the Champs-Élysées on 7 June 2024.

The Théâtre du Lido offers visitors an immersive multi-sensory attraction every day from 11am to 8pm, engulfing them in an artistic vision inspired by the revisited and enhanced music of Vivaldi's Four Seasons.

With climate change, the four distinct seasons are becoming increasingly uncertain. With the help of artificial... (continue reading...)

RANCHO CUCAMONGA, CA / ACCESSWIRE / June 3, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO, and Jacob Liawatidewi, EVP of Corporate Administration, will participate in an Analyst-Moderated fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 12:30 pm EST. For access, visit Amphastar's Pharmaceuticals website at http://ir.amphastar.com. This webcast will be available for 30 days following... (continue reading...)

At a median planned follow-up of the Phase 2b study at 34.9 months, mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 49% and the risk of distant metastasis or death by 62% compared to KEYTRUDA alone in these patients

The 2.5-year recurrence-free survival rate of mRNA-4157 (V940) in combination with KEYTRUDA was 74.8% as compared to 55.6% for KEYTRUDA alone, with the benefit observed across exploratory subgroups

The companies have... (continue reading...)

Des Moines, IA, June 03, 2024 (GLOBE NEWSWIRE) -- LCS has announced the finalists for the 2024 LCS “Chef of the Year” competition. The annual competition celebrates the hospitality and culinary talents of chefs in senior living communities owned and managed by Life Care Services. Chef of the Year finalists were selected by a steering committee that reviewed applicant recipes, plated dishes, and videos highlighting work in their respective communities. 

Five... (continue reading...)

~ Geoff Birkett, Chief Commercial Officer, Invited to Serve on the Opening Panel at the EPHMRA 2024 Annual Conference ~

SAN DIEGO, CA / ACCESSWIRE / June 3, 2024 / Ensysce Biosciences, Inc. (NASDAQ: ENSC) ("Ensysce" or the "Company"), a clinical stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid misuse, abuse and overdose, today announced that Geoff Birkett, the Company's Chief Commercial Officer,... (continue reading...)